Purpose: To report the characteristics and correlation of visual acuity in eyes treated for neovascular age-related macular degeneration (nAMD) and developed fibrosis.
Design: Case-control study.
Methods: Three hundred fifty-six treatment-naive nAMD eyes that were treated for 12 months were included. Fibrosis was defined as present if well-defined hyperreflective material (HRM) were present between the neurosensory retina and the Bruch membrane on optical coherence tomography (OCT) that correlated with well-defined regions of yellowish pallor on fundus photography and/or staining on fluorescence angiography. OCT features of subfoveal fibrosis and the overlying retina were correlated with visual acuity at month 12.
Results: Sixty-three eyes (20.3%) developed incident fibrosis at month 12. Compared with eyes that did not develop fibrosis, these eyes had lower baseline vision (49 vs 54 letters, P = .02) and more of them had type 2 macular neovascularization (15.0 vs 8.8%, P = .03), larger lesion area (29.6 vs 15.1 mm, P = .02), and subretinal hemorrhage ≥4 disc diameters (44.4% vs 19.8%, P < .01). Visual acuity was worse in the incident fibrosis compared with the group that never developed fibrosis by month 12. (-1.4±17.1 versus +6.0±17.4 letters, P < .01). In 83 eyes that had subfoveal fibrosis, better vision was associated with intact ellipsoid zone-external limiting membrane complex (β coefficient 29.4, 95% CI 14.2-44.6, P < .01), whereas worse vision was associated with retinal pigment epithelium (RPE)-involving HRM, HRM above the RPE, and width of HRM (β coefficients -25.4 [95% CI -36.3 to -14.6], P < .01; -23.5 [95% CI -39.0 to -7.9], P < .01; and -3.8 [95% CI -7.2 to -0.4], P = .03, respectively).
Conclusion: Although fibrosis is associated with poorer visual outcome, preservation of external limiting membrane and level of fibrosis relative to the RPE are associated with visual outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajo.2023.12.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes.
Mol Ther
September 2024
Department of Ophthalmology & Vision Sciences, University of California Davis, Davis, CA 95616, USA. Electronic address:
CRISPR-based genome editing enables permanent suppression of angiogenic factors such as vascular endothelial growth factor (VEGF) as a potential treatment for choroidal neovascularization (CNV)-a major cause of blindness in age-related macular degeneration. We previously designed adeno-associated viral (AAV) vectors with S. pyogenes Cas 9 (SpCas9) and guide RNAs (gRNAs) to target conserved sequences in VEGFA across mouse, rhesus macaque, and human, with successful suppression of VEGF and laser-induced CNV in mice.
View Article and Find Full Text PDFBackground And Objective: We compared assistance burden between neovascular age-related macular degeneration (nAMD) and retinal angiomatous proliferation (RAP) under intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment on a treat-and-extend (T&E) regimen in a third-level hospital in a developed country.
Patients And Methods: This retrospective study using data from the Fight Retinal Blindness! Registry included patients treated between January 2016 and December 2020. Final event was established as best corrected visual acuity (BCVA) lower than 20 Early Treatment Diabetic Retinopathy Study letters.
Features Associated With Vision in Eyes With Subfoveal Fibrosis From Neovascular Age-Related Macular Degeneration.
Am J Ophthalmol
May 2024
From the Singapore Eye Research Institute, Singapore National Eye Centre (K.Y.C.T., J.Z., F.I.I., B.F., C.M.G.C.), Singapore; Duke-NUS Medical School, National University of Singapore (K.Y.C.T., F.I.I., B.F., C.M.G.C.), Singapore. Electronic address:
Purpose: To report the characteristics and correlation of visual acuity in eyes treated for neovascular age-related macular degeneration (nAMD) and developed fibrosis.
Design: Case-control study.
Methods: Three hundred fifty-six treatment-naive nAMD eyes that were treated for 12 months were included.
Subfoveal Nodule Affecting Visual Prognosis in Coats Disease.
Korean J Ophthalmol
February 2024
Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Article Synopsis
- The study investigates the characteristics of subfoveal nodules in Korean patients with Coats disease and how they relate to visual outcomes.
- Among 12 patients analyzed, 75% had subfoveal nodules, and these patients experienced significantly more severe visual loss and developed macular fibrosis.
- The findings suggest that the presence of subfoveal nodules predicts worse visual outcomes, highlighting the need for larger studies and treatment approaches for these conditions.
Aneurysmal type 2 neovascularization: A new entity.
J Fr Ophtalmol
February 2024
Department of Ophthalmology, Universitario of Valencia, Consorcio Hospital General, avenida Tres-Cruces, 2, 46014 Valencia, Spain.
Purpose: To report three cases of aneurysmal type 2 neovascularization (AT2), a novel entity within the pachychoroid disease (PD) spectrum.
Methods: We conducted an observational retrospective study of three patients with subretinal polyps treated with intravitreal aflibercept. We reviewed clinical and imaging data of the three patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!